Home

eficient Maimuţă Shinkan ticagrelor dose after pci plic numai Strălucire

Implications of the Antiplatelet Therapy Gap Left With Discontinuation of  Prasugrel in Canada - CJC Open
Implications of the Antiplatelet Therapy Gap Left With Discontinuation of Prasugrel in Canada - CJC Open

Antiplatelet therapy in coronary artery disease
Antiplatelet therapy in coronary artery disease

Premature Ticagrelor Discontinuation in Secondary Prevention of  Atherosclerotic CVD: JACC Review Topic of the Week - ScienceDirect
Premature Ticagrelor Discontinuation in Secondary Prevention of Atherosclerotic CVD: JACC Review Topic of the Week - ScienceDirect

Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing  Complex Percutaneous Coronary Intervention | Circulation: Cardiovascular  Interventions
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions

Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in  Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Percutaneous  Coronary Intervention: A Randomized Clinical Trial
Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial

Low-dose ticagrelor yields an antiplatelet efficacy similar to that of  standard-dose ticagrelor in healthy subjects: an open-label randomized  controlled trial | Scientific Reports
Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial | Scientific Reports

2018 Canadian Cardiovascular Society/Canadian Association of Interventional  Cardiology Focused Update of the Guidelines for the Use of Antiplatelet  Therapy - Canadian Journal of Cardiology
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy - Canadian Journal of Cardiology

Double (360mg) Loading Dose Of Ticagrelor In Patients With ST-elevation  Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention  | tctmd.com
Double (360mg) Loading Dose Of Ticagrelor In Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention | tctmd.com

Brilinta (Ticagrelor Tablets for Oral Administration): Uses, Dosage, Side  Effects, Interactions, Warning
Brilinta (Ticagrelor Tablets for Oral Administration): Uses, Dosage, Side Effects, Interactions, Warning

Frontiers | Effects of Clopidogrel, Prasugrel and Ticagrelor on  Microvascular Function and Platelet Reactivity in Patients With Acute  Coronary Syndrome Undergoing Coronary Artery Stenting. A Randomized,  Blinded, Parallel Group Trial | Cardiovascular ...
Frontiers | Effects of Clopidogrel, Prasugrel and Ticagrelor on Microvascular Function and Platelet Reactivity in Patients With Acute Coronary Syndrome Undergoing Coronary Artery Stenting. A Randomized, Blinded, Parallel Group Trial | Cardiovascular ...

JCM | Free Full-Text | De-Escalation of Antiplatelet Treatment in Patients  with Myocardial Infarction Who Underwent Percutaneous Coronary Intervention:  A Review of the Current Literature | HTML
JCM | Free Full-Text | De-Escalation of Antiplatelet Treatment in Patients with Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Review of the Current Literature | HTML

Dual antiplatelet therapy after percutaneous coronary intervention:  entering the final chapter? - EuroIntervention
Dual antiplatelet therapy after percutaneous coronary intervention: entering the final chapter? - EuroIntervention

Ticagrelor and preconditioning in patients with stable coronary artery  disease (TAPER-S): a randomized pilot clinical trial | Trials | Full Text
Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): a randomized pilot clinical trial | Trials | Full Text

Ticagrelor Dosage Guide + Max Dose, Adjustments - Drugs.com
Ticagrelor Dosage Guide + Max Dose, Adjustments - Drugs.com

Ticagrelor versus clopidogrel in acute myocardial infarction patients with  multivessel disease; From Korea Acute Myocardial Infarction  Registry-National Institute of Health - Journal of Cardiology
Ticagrelor versus clopidogrel in acute myocardial infarction patients with multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health - Journal of Cardiology

Figure 1 from Comparison of Prasugrel and Ticagrelor Antiplatelet Effects  in Korean Patients Presenting With ST-Segment Elevation Myocardial  Infarction. | Semantic Scholar
Figure 1 from Comparison of Prasugrel and Ticagrelor Antiplatelet Effects in Korean Patients Presenting With ST-Segment Elevation Myocardial Infarction. | Semantic Scholar

2 1 Intensification strategies
2 1 Intensification strategies

Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing  Multivessel PCI - ScienceDirect
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI - ScienceDirect

Effectiveness and Safety of Ticagrelor Implementation in Patients with  Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention: A  Cohort Study in Western Denmark - The Lancet Regional Health – Europe
Effectiveness and Safety of Ticagrelor Implementation in Patients with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention: A Cohort Study in Western Denmark - The Lancet Regional Health – Europe

Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With  Low-Risk ACS Undergoing Ad Hoc PCI - ScienceDirect
Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI - ScienceDirect

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention  (ALPHEUS): a randomised, open-label, phase 3b trial - The Lancet
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial - The Lancet

Efficacy and safety of standard and low dose ticagrelor versus clopidogrel  in east AsianPatients with chronic total occlusion undergoing percutaneous  coronary intervention: a single center retrospective study | BMC  Cardiovascular Disorders
Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in east AsianPatients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study | BMC Cardiovascular Disorders

Comparison of therapy with Ticagrelor, Prasugrel or high Clopidogrel dose  in PCI patients with high on treatment platelet reactivity and genotype  variation. TRIPLETE RESET trial - International Journal of Cardiology
Comparison of therapy with Ticagrelor, Prasugrel or high Clopidogrel dose in PCI patients with high on treatment platelet reactivity and genotype variation. TRIPLETE RESET trial - International Journal of Cardiology

Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in  Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Percutaneous  Coronary Intervention: A Randomized Clinical Trial | Journal of the  American Heart Association
Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial | Journal of the American Heart Association

Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI:  SWAP-4 | tctmd.com
Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4 | tctmd.com

Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in  Patients Undergoing PCI | JACC: Cardiovascular Interventions
Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI | JACC: Cardiovascular Interventions

Double Versus Standard Loading Dose of Ticagrelor: Onset of Antiplatelet  Action in Patients With STEMI Undergoing Primary PCI | Journal of the  American College of Cardiology
Double Versus Standard Loading Dose of Ticagrelor: Onset of Antiplatelet Action in Patients With STEMI Undergoing Primary PCI | Journal of the American College of Cardiology

VisualAbstract: Ticagrelor non-superior to clopidogrel in the reduction of  PCI-related myocardial necrosis | 2 Minute Medicine
VisualAbstract: Ticagrelor non-superior to clopidogrel in the reduction of PCI-related myocardial necrosis | 2 Minute Medicine